Pyridam Farma Tbk PT
IDX:PYFA
Pyridam Farma Tbk PT
IDX:PYFA
Price:
206
IDR
-4.63%
Market Cap:
2.3T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
PYFA Alert
Pyridam Farma Tbk PT
206
-10 (-4.63%)
| 52 Week Range |
89
1 350
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Pyridam Farma Tbk PT
Balance Sheet
Balance Sheet Decomposition
Pyridam Farma Tbk PT
Pyridam Farma Tbk PT
| Current Assets | 1.7T |
| Cash & Short-Term Investments | 505.4B |
| Receivables | 617.5B |
| Other Current Assets | 589.9B |
| Non-Current Assets | 4.2T |
| Long-Term Investments | 99.7B |
| PP&E | 1.5T |
| Intangibles | 2.5T |
| Other Non-Current Assets | 21.1B |
| Current Liabilities | 2.3T |
| Accounts Payable | 303.6B |
| Accrued Liabilities | 98.5B |
| Short-Term Debt | 1.7T |
| Other Current Liabilities | 184.3B |
| Non-Current Liabilities | 2.4T |
| Long-Term Debt | 2.1T |
| Other Non-Current Liabilities | 291.3B |
Balance Sheet
Pyridam Farma Tbk PT
Pyridam Farma Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2 926
|
3 728
|
1 365
|
380
|
1 953
|
5 295
|
0
|
0
|
0
|
89 970
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
5 295
|
0
|
0
|
0
|
89 970
|
|
| Cash Equivalents |
2 926
|
3 728
|
1 365
|
380
|
1 953
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
39 597
|
30 246
|
38 716
|
37 328
|
42 693
|
41 965
|
60 334
|
100 991
|
151 755
|
198 463
|
|
| Accounts Receivables |
39 597
|
30 246
|
38 716
|
37 328
|
42 693
|
41 551
|
59 304
|
94 126
|
148 948
|
188 691
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
414
|
1 030
|
6 865
|
2 807
|
9 772
|
|
| Inventory |
32 258
|
36 164
|
40 301
|
36 891
|
41 590
|
44 270
|
51 036
|
145 941
|
210 194
|
225 484
|
|
| Other Current Assets |
3 296
|
2 609
|
2 724
|
3 766
|
5 151
|
4 417
|
8 337
|
31 766
|
42 464
|
56 621
|
|
| Total Current Assets |
78 078
|
72 746
|
83 106
|
78 364
|
91 387
|
95 946
|
129 342
|
326 431
|
540 992
|
570 538
|
|
| PP&E Net |
91 716
|
84 152
|
79 955
|
75 930
|
90 378
|
88 398
|
96 247
|
386 757
|
846 694
|
810 246
|
|
| PP&E Gross |
91 716
|
0
|
0
|
75 930
|
90 378
|
88 398
|
96 247
|
386 757
|
846 694
|
810 246
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
85 103
|
88 408
|
91 590
|
90 197
|
156 314
|
393 335
|
441 312
|
|
| Intangible Assets |
97
|
100
|
97
|
100
|
121
|
141
|
266
|
44 830
|
11 170
|
19 111
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
40 240
|
100 594
|
100 082
|
|
| Other Long-Term Assets |
2 667
|
2 954
|
3 905
|
5 170
|
5 171
|
6 300
|
2 720
|
7 963
|
21 118
|
21 255
|
|
| Total Assets |
172 557
N/A
|
159 952
-7%
|
167 063
+4%
|
159 564
-4%
|
187 057
+17%
|
190 786
+2%
|
228 575
+20%
|
806 222
+253%
|
1 520 569
+89%
|
1 521 233
+0%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
6 591
|
3 629
|
5 981
|
6 737
|
8 745
|
8 494
|
9 259
|
95 400
|
68 694
|
62 846
|
|
| Accrued Liabilities |
1 133
|
166
|
958
|
626
|
1 266
|
690
|
639
|
16 849
|
50 444
|
54 363
|
|
| Short-Term Debt |
28 642
|
22 050
|
21 561
|
8 389
|
15 500
|
10 404
|
21 468
|
65 000
|
137 429
|
131 213
|
|
| Current Portion of Long-Term Debt |
7 945
|
7 327
|
5 311
|
1 366
|
2 346
|
2 932
|
6 037
|
21 011
|
22 378
|
20 221
|
|
| Other Current Liabilities |
3 684
|
3 362
|
4 123
|
5 128
|
5 285
|
4 678
|
7 346
|
53 578
|
18 444
|
25 072
|
|
| Total Current Liabilities |
47 995
|
36 534
|
37 934
|
22 245
|
33 142
|
27 198
|
44 749
|
251 838
|
297 388
|
293 715
|
|
| Long-Term Debt |
11 054
|
4 112
|
856
|
512
|
6 676
|
6 074
|
8 008
|
362 803
|
750 231
|
835 557
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
231
|
226
|
|
| Other Liabilities |
16 412
|
18 083
|
22 764
|
27 951
|
28 312
|
32 788
|
18 187
|
24 480
|
30 592
|
34 901
|
|
| Total Liabilities |
75 461
N/A
|
58 729
-22%
|
61 554
+5%
|
50 708
-18%
|
68 130
+34%
|
66 060
-3%
|
70 944
+7%
|
639 122
+801%
|
1 078 442
+69%
|
1 164 399
+8%
|
|
| Equity | |||||||||||
| Common Stock |
53 508
|
53 508
|
53 508
|
53 508
|
53 508
|
53 508
|
53 508
|
53 508
|
53 508
|
53 508
|
|
| Retained Earnings |
41 524
|
45 649
|
49 936
|
53 283
|
63 354
|
69 153
|
91 948
|
97 427
|
372 668
|
287 447
|
|
| Additional Paid In Capital |
2 065
|
2 065
|
2 065
|
2 065
|
2 065
|
2 065
|
2 065
|
2 065
|
2 064
|
2 064
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
10 111
|
14 100
|
13 885
|
13 815
|
|
| Total Equity |
97 097
N/A
|
101 222
+4%
|
105 509
+4%
|
108 856
+3%
|
118 928
+9%
|
124 726
+5%
|
157 632
+26%
|
167 100
+6%
|
442 126
+165%
|
356 834
-19%
|
|
| Total Liabilities & Equity |
172 557
N/A
|
159 952
-7%
|
167 063
+4%
|
159 564
-4%
|
187 057
+17%
|
190 786
+2%
|
228 575
+20%
|
806 222
+253%
|
1 520 569
+89%
|
1 521 233
+0%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
535
|
535
|
535
|
535
|
535
|
535
|
535
|
2 492
|
2 492
|
2 492
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
